2020
DOI: 10.1055/a-1125-7455
|View full text |Cite
|
Sign up to set email alerts
|

MRT bei neurodegenerativen Erkrankungen

Abstract: Neurodegenerative Erkrankungen nehmen in einer älter werdenden Gesellschaft stark zu. Bei klinischem Verdacht lassen sich diese Erkrankungen häufig anhand krankheitsspezifischer Atrophiemuster diagnostizieren. Die Erkennung wird erleichtert, wenn der Datensatz des Patienten mit einer Gruppe „alters- und geschlechtsgematchter“ Kontrollen verglichen und Voxel bzw. Regionen, die sich unterscheiden, hervorgehoben werden.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

3
0

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 7 publications
(7 reference statements)
0
2
0
1
Order By: Relevance
“…Despite the low number of patients and the retrospective data collection this single-center proof of concept study shows that NPH patients can be automatically detected with a high accuracy similar to human ratings. This detection is helpful as a NPH pattern often interferes with voxel-based morphometry to detect region-specific atrophy [ 28 ]; however, use needs to be confirmed by a larger and more structured data assessment. In this context, the comparison of the SVM prediction score with a recently published visual imaging score (iNPH Radscale) would be worthwhile [ 29 ].…”
Section: Discussionmentioning
confidence: 99%
“…Despite the low number of patients and the retrospective data collection this single-center proof of concept study shows that NPH patients can be automatically detected with a high accuracy similar to human ratings. This detection is helpful as a NPH pattern often interferes with voxel-based morphometry to detect region-specific atrophy [ 28 ]; however, use needs to be confirmed by a larger and more structured data assessment. In this context, the comparison of the SVM prediction score with a recently published visual imaging score (iNPH Radscale) would be worthwhile [ 29 ].…”
Section: Discussionmentioning
confidence: 99%
“…Mit der Möglichkeit, multiplanare Reformatierungen aus isotropen MRT- aber auch aus CT-Datensätzen herstellen zu können, wurde dann die Erkennung spezifischer Atrophiemuster verbessert, sodass primäre Demenzerkrankungen und hier hauptsächlich der Morbus Alzheimer diagnostiziert werden konnten. In einem nächsten Schritt wurden weniger ausgeprägte Atrophiemuster durch den Voxel- und Regionen-basierten Vergleich mit gleichaltrigen Gesunden herausgearbeitet und KI-basierte Diagnosewahrscheinlichkeiten implementiert 3 4 . Schließlich sollen nach dem Abschluss von Phase-III-Studien und der Zulassung durch die FDA Alzheimer-Patienten in frühen Stadien der Erkrankung (mit mutmaßlich gering ausgeprägten Atrophien) mit monoklonalen Antikörpern behandelt werden, die das im Hirnparenchym abgelagerte Amyloid „herauswaschen“ sollen.…”
Section: Abkürzungenunclassified
“…The ability to create multiplanar reconstructions from isotropic MRI as well as CT datasets improved the detection of specific patterns of atrophy so that the primary types of dementia, primarily Alzheimer’s disease, were able to be diagnosed. In a next step, less pronounced patterns of atrophy were identified based on a voxel- and region-based comparison with healthy subjects of the same age and AI-based diagnosis probabilities were implemented 3 4 . Finally, after the conclusion of phase III studies and approval by the FDA, Alzheimer’s patients in early stages of the disease (presumably with minimal atrophy) are to be treated with monoclonal antibodies to clear amyloid deposits in the brain parenchyma.…”
Section: Abbreviationsmentioning
confidence: 99%